BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22889922)

  • 1. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.
    Brown BM; Peiffer JJ; Taddei K; Lui JK; Laws SM; Gupta VB; Taddei T; Ward VK; Rodrigues MA; Burnham S; Rainey-Smith SR; Villemagne VL; Bush A; Ellis KA; Masters CL; Ames D; Macaulay SL; Szoeke C; Rowe CC; Martins RN
    Mol Psychiatry; 2013 Aug; 18(8):875-81. PubMed ID: 22889922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
    Snellman A; Ekblad LL; Tuisku J; Koivumäki M; Ashton NJ; Lantero-Rodriguez J; Karikari TK; Helin S; Bucci M; Löyttyniemi E; Parkkola R; Karrasch M; Schöll M; Zetterberg H; Blennow K; Rinne JO
    Alzheimers Res Ther; 2023 Apr; 15(1):71. PubMed ID: 37016464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma and cortical amyloid beta is modulated by APOE ε4 status.
    Swaminathan S; Risacher SL; Yoder KK; West JD; Shen L; Kim S; Inlow M; Foroud T; Jagust WJ; Koeppe RA; Mathis CA; Shaw LM; Trojanowski JQ; Soares H; Aisen PS; Petersen RC; Weiner MW; Saykin AJ;
    Alzheimers Dement; 2014 Jan; 10(1):e9-e18. PubMed ID: 23541187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderating effect of
    Hwang JY; Byun MS; Choe YM; Lee JH; Yi D; Choi JW; Hwang SH; Lee YJ; Lee DY;
    Neurology; 2018 Mar; 90(13):e1167-e1173. PubMed ID: 29490913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E ε4 Allele is Associated With Plasma Amyloid Beta and Amyloid Beta Transporter Levels: A Cross-sectional Study in a Rural Area of Xi'an, China.
    Wei S; Gao L; Jiang Y; Shang S; Chen C; Dang L; Zhao B; Zhang J; Wang J; Huo K; Wang J; Zhang R; Qu Q
    Am J Geriatr Psychiatry; 2020 Feb; 28(2):194-204. PubMed ID: 31350163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.
    Rainey-Smith SR; Gu Y; Gardener SL; Doecke JD; Villemagne VL; Brown BM; Taddei K; Laws SM; Sohrabi HR; Weinborn M; Ames D; Fowler C; Macaulay SL; Maruff P; Masters CL; Salvado O; Rowe CC; Scarmeas N; Martins RN
    Transl Psychiatry; 2018 Oct; 8(1):238. PubMed ID: 30375373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E4 Mediates the Association Between Midlife Dyslipidemia and Cerebral Amyloid in Aging Women.
    Szoeke C; Goodwill AM; Gorelik A; Dennerstein L; Caeyenberghs K; Simpson S; Hill E; Campbell S
    J Alzheimers Dis; 2019; 68(1):105-114. PubMed ID: 30689578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ankle-Brachial Index Is Associated with Cerebral β-Amyloid Deposition in Cognitively Normal Older Adults.
    Moon SW; Byun MS; Yi D; Lee JH; Jeon SY; Lee Y; Kee BS; Lee DY;
    J Gerontol A Biol Sci Med Sci; 2019 Jun; 74(7):1141-1148. PubMed ID: 29982493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults.
    Slee MG; Rainey-Smith SR; Villemagne VL; Doecke JD; Sohrabi HR; Taddei K; Ames D; Dore V; Maruff P; Laws SM; Masters CL; Rowe CC; Martins RN; Erickson KI; Brown BM
    Alzheimers Dement; 2024 Feb; 20(2):1350-1359. PubMed ID: 37984813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.
    Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith S; Robertson J; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2018; 65(4):1313-1325. PubMed ID: 30149452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Daily Physical Activity by Alzheimer's Risk Markers Among Older Adults.
    Marino FR; Deal JA; Dougherty RJ; Bilgel M; Tian Q; An Y; Simonsick EM; Resnick SM; Ferrucci L; Spira AP; Wanigatunga AA; Schrack JA
    J Gerontol A Biol Sci Med Sci; 2024 Jul; 79(7):. PubMed ID: 38742659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association Between Alzheimer's Disease-Related Markers and Physical Activity in Cognitively Normal Older Adults.
    Pedrini S; Chatterjee P; Nakamura A; Tegg M; Hone E; Rainey-Smith SR; Rowe CC; Dore V; Villemagne VL; Ames D; Kaneko N; Gardener SL; Taddei K; Fernando B; Martins I; Bharadwaj P; Sohrabi HR; Masters CL; Brown B; Martins RN
    Front Aging Neurosci; 2022; 14():771214. PubMed ID: 35418852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM
    Neurobiol Aging; 2019 Apr; 76():162-165. PubMed ID: 30716541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.
    Hilal S; Wolters FJ; Verbeek MM; Vanderstichele H; Ikram MK; Stoops E; Ikram MA; Vernooij MW
    Alzheimers Res Ther; 2018 Jun; 10(1):63. PubMed ID: 29960604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between amylin and amyloid-β peptides in plasma in the context of apolipoprotein E4 allele.
    Qiu WQ; Wallack M; Dean M; Liebson E; Mwamburi M; Zhu H
    PLoS One; 2014; 9(2):e88063. PubMed ID: 24520345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hypertension on brain amyloid deposition and Alzheimer's disease signature neurodegeneration.
    Jeon SY; Byun MS; Yi D; Lee JH; Choe YM; Ko K; Sohn BK; Choi HJ; Lee JY; Lee DY;
    Neurobiol Aging; 2019 Mar; 75():62-70. PubMed ID: 30553154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.
    Pedrini S; Hone E; Gupta VB; James I; Teimouri E; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Rainey-Smith S; Verdile G; Sohrabi HR; Raida MR; Wenk MR; Taddei K; Chatterjee P; Martins I; Laws SM; Martins RN;
    J Alzheimers Dis; 2020; 77(2):733-744. PubMed ID: 32741823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Aβ
    Doecke JD; Pérez-Grijalba V; Fandos N; Fowler C; Villemagne VL; Masters CL; Pesini P; Sarasa M;
    Neurology; 2020 Apr; 94(15):e1580-e1591. PubMed ID: 32179698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midlife insulin resistance,
    Ekblad LL; Johansson J; Helin S; Viitanen M; Laine H; Puukka P; Jula A; Rinne JO
    Neurology; 2018 Mar; 90(13):e1150-e1157. PubMed ID: 29476033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease.
    Chatterjee P; Pedrini S; Stoops E; Goozee K; Villemagne VL; Asih PR; Verberk IMW; Dave P; Taddei K; Sohrabi HR; Zetterberg H; Blennow K; Teunissen CE; Vanderstichele HM; Martins RN
    Transl Psychiatry; 2021 Jan; 11(1):27. PubMed ID: 33431793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.